Has the IPL, its players and fans become secondary as big companies cynically use India's most followed and visible sport to push their phone or toothpaste brands?
Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.
Akhilesh Yadav is now seeking to devote the remaining 18 months of his tenure in casting the state in a new mould.
Just one year after taking office, Prime Minister Narendra Modi is facing a challenge that could come to haunt him.
For debt-laden companies, asset sales is an obvious solution.
Data also show that several other leading domestic pharma companies have recalled their products from the US
A gun battle was still continuing inside the old airport near the hangars and workshop as military and other security personnel tried to clear up the runaway and surrounding area from the terrorists.
Sentiment has improved but no progress on GST & ending 'tax terrorism' disappoints.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
Six money lessons you can learn from the popular game
David Coleman Headley pens down his life as a terrorist and his turn towards extremism in his new memoir.
"A Meryl Streep or Jimmy Kimmel can speak their mind, and stay assured that they won't be harmed. That does not happen in India," say Manavi Kapur & Ranjita Ganesan.
Ranbaxy did its maiden public issue in 1973.
Modi government has to come up with a robust economic agenda to impress the masses.
A look at the life and times of maverick businessman Chinnakannan Sivasankaran
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances